BlueSphere Bio
BlueSphere Bio is a t Cell Therapy founded in 2018.
All edits by Marina Surdu
Edits on 25 Jul, 2022
Marina Surdu
Edits made to:
Timeline (+11 events) (+1124 characters)
Timeline
June 13, 2022
BlueSphere Bio to Present a Corporate Overview at the 2022 BIO International Convention | BlueSphere Bio
May 25, 2022
BlueSphere Bio Data to be Presented at the 2022 Joint ASTCT + EBMT Basic and Translational Scientific Retreat | BlueSphere Bio
April 26, 2022
BlueSphere Bio Appoints Robert Keefe, Ph.D. as Chief Development Office | BlueSphere Bio
April 8, 2022
BlueSphere Bio Presents New Data Supporting the Potential of its TCXpressTM Platform at the 2022 AACR Meeting | BlueSphere Bio
March 15, 2022
BlueSphere Bio Data to be Presented at the 2022 American Association for Cancer Research Annual Meeting | BlueSphere Bio
February 8, 2022
BlueSphere Bio to Present at the BIO CEO & Investor Conference | BlueSphere Bio
August 19, 2021
BlueSphere Bio appoints industry veteran Jonathan Peacock as Chairman of the Board | BlueSphere Bio
October 29, 2020
BlueSphere Bio Names Dr. Alan Korman to Board of Directors | BlueSphere Bio
July 22, 2020
BlueSphere Bio Appoints Drug Development Leader Dr. Michael Geffner as Chief Medical Officer | BlueSphere Bio
July 9, 2020
BlueSphere Bio Names Immune Oncology Pioneers to Scientific Advisory Board | BlueSphere Bio
July 31, 2019
Immune Oncology Innovator BlueSphere Bio Names Veteran Biotech Leader David Apelian as CEO | BlueSphere Bio
Find more companies like BlueSphere Bio
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
